Wegovy pill approved by US FDA for weight loss

The US Meals and Drug Administration (FDA) has permitted a tablet model of the weight-loss drug Wegovy, in accordance with pharmaceutical large Novo Nordisk.It’s the first tablet of its sort to obtain approval from the regulator, marking a brand new period for weight-loss medication.Wegovy’s Danish makers Novo Nordisk stated the once-daily tablet was a “handy possibility” to the injectable and would supply the identical weight reduction because the shot. It comes after Wegovy was permitted by the FDA particularly for weight reduction.Others like Ozempic, which has related weight-loss results, have been primarily permitted for the therapy of Kind 2 diabetes.The BBC has contacted the FDA for remark.The Wegovy tablet confirmed a mean weight lack of 16.6% throughout Novo Nordisk’s trials, the agency stated on Monday.A 3rd of round 1,300 members skilled 20% or larger weight reduction in the identical trial, it added.The tablet is anticipated to be launched within the US in early January 2026.”Sufferers can have a handy, once-daily tablet that may assist them lose as a lot weight as the unique Wegovy injection,” stated Mike Doustdar, the agency’s chief govt.The tablet model of Wegovy might give Novo Nordisk’s gross sales a lift after a difficult 12 months which noticed its shares slide because it warned over its earnings.The corporate has confronted intense competitors within the weight-loss market from rival drugmakers like Eli Lilly.Novo Nordisk’s shares rose by virtually 10% in after-hours commerce in New York after the announcement.